BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

9 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Emerging targets in osteoporosis disease modification.EBI
Amgen
Effect of cathepsin K inhibitors on bone resorption.EBI
Novartis Institutes For Biomedical Research
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?EBI
Glaxosmithkline
Acyclic cyanamide-based inhibitors of cathepsin K.EBI
Glaxosmithkline
Design of small molecule ketoamide-based inhibitors of cathepsin K.EBI
Glaxosmithkline
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.EBI
Glaxosmithkline
Azepanone-based inhibitors of human and rat cathepsin K.EBI
Glaxosmithkline
NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.BDB
Novo Nordisk